CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs
Abroad (travel likely)Recruiting
Conditions
Wound, Foot · Diabetic Foot Ulcer (DFU) · Venus Leg Ulcer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
North Park Podiatry, San Diego, California, United States
Contact: Principal Investigator (Trent Brookshier)Solutions Medical Research, Coral Gables, Florida, United States
Contact: Principal Investigator (Francisco Jose Oliva)NAR Medical and Research, Miami, Florida, United States
Contact: Principal Investigator (Julio Arronte)Nova Medical Services - Research Division LLC, Miami, Florida, United States
Contact: Principal Investigator (Sandor Romero)Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States
Contact: Principal Investigator (Mithun Sinha)St. Louis Foot and Ankle, LLC, St Louis, Missouri, United States
Contact: Principal Investigator (Raymond Abdo)Hope Vascular and Podiatry, Houston, Texas, United States
Contact: Principal Investigator (Brian Lepow)
Study leads
Windy Cole, DPM
Study Director
Capsicure, LLC